U. Fink

10.6k citations

165 papers · 7.8k indexed · 3 hit papers · h-index 45

Impact in

Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment
Pulmonary and Respiratory Medicine top 0.2%
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
- Lung Cancer Diagnosis and Treatment

Papers in

Gastroenterology 18
- Gastrointestinal Tumor Research and Treatment 18
Pulmonary and Respiratory Medicine 80
- Gastric Cancer Management and Outcomes 57
- Metastasis and carcinoma case studies 19
- Lung Cancer Diagnosis and Treatment 11

Co-authors: Karen Becker H. J. Stein Katja Ott Markus Schwaiger Wolfgang Weber J. R. Siewert Raymonde Busch Florian Lordick
Journals: Journal of Clinical Oncology (7 papers)World Journal of Surgery (7 papers)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (6 papers)Cancer (5 papers)Annals of Hematology (5 papers)
Partner nations: Germany United States Austria

In The Last Decade

U. Fink

159 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial 2007 · 550 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 The Lancet Oncology
2003 Cancer
2001 Journal of Clinical Oncology

Peers

Countries citing papers authored by U. Fink

Since Specialization

Citations

This map shows the geographic impact of U. Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Fink more than expected).

Fields of papers citing papers by U. Fink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Fink. The network helps show where U. Fink may publish in the future.

Co-authors

The 25 scholars most cited alongside U. Fink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with U. Fink Line = papers co-authored together U. Fink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Update Polytrauma und Computertomographie unter Reanimationsbedingungen Der Radiologe ·Alexander Gäble, Johannes Hebebrand, Marco Armbruster, Fabian Mück, Maria Berndt, Bernhard Kumle, U. Fink, Stefan Wirth	2020	3
2	Konzept einer interdisziplinären Notaufnahmeklinik am Schwarzwald-Baar Klinikum Medizinische Klinik - Intensivmedizin und Notfallmedizin ·Bernhard Kumle, S. Merz, M. Geiger, K. -E. Kugel, U. Fink	2014	4
3	Induction Chemotherapy in Barrett Cancer Annals of Surgery ·J. R. Siewert, Florian Lordick, Katja Ott, H. J. Stein, Wolfgang Weber, Karen Becker, Christian Peschel, U. Fink, Markus Schwaiger	2007	40
4	FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings European Journal of Nuclear Medicine and Molecular Imaging ·Alexander Stahl, Katja Ott, Wolfgang Weber, Karen Becker, Thomas M. Link, Jörg‐Rüdiger Siewert, Markus Schwaiger, U. Fink	2003	243
5	Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy Surgery ·Claus-Dieter Heidecke, Heike Weighardt, Marcus Feith, U. Fink, Frank Zimmermann, H. J. Stein, Jörg‐Rüdiger Siewert, Bernhard Holzmann	2002	54
6	Ceramic and PMMA particles differentially affect osteoblast phenotype Biomaterials ·Christoph H. Lohmann, David D. Dean, Georg Köster, David Casasola, Gottfried Buchhorn, U. Fink, Zvi Schwartz, Barbara D. Boyan	2002	101
7	Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer British Journal of Cancer ·Paul M. Schneider, H W Praeuer, Oliver Stoeltzing, Joachim Boehm, John T. Manning, Ralf Metzger, U. Fink, S. Wegerer, Arnulf H. Hoelscher, Jack A. Roth	2000	71
8	Influence of Simultaneous Neoadjuvant Radiotherapy and Chemotherapy on Bronchoscopic Findings and Lung Function in Patients with Locally Advanced Proximal Esophageal Cancer American Journal of Respiratory and Critical Care Medicine ·Martin Riedel, H. J. Stein, Leonard Mounyam, Frank Zimmermann, U. Fink, Jörg Rudiger Siewert	2000	10
9	Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities International Journal of Cancer ·Mario Sarbia, M. Stahl, U. Fink, Hansj�rg Heep, Philipp Dutkowski, Rainhart Willers, S. Seeber, Helmut E. Gabbert	1999	55
10	Surgical resection for cancer of the cardia Seminars in Surgical Oncology ·J. R. Siewert, H. J. Stein, A. Sendler, U. Fink	1999	52
11	Bedeutung des Tumordebulkings bei gastrointestinalen Tumoren Der Chirurg ·Markus Puhlmann, U. Fink, J. R. Siewert	1999	2
12	Multimodale Therapie bei Tumoren des oberen Gastrointestinaltrakts Der Chirurg ·U. Fink, H. J. Stein, J. R. Siewert	1998	21
13	Safety considerations in the coating of titanium bearing components Der Orthopäde ·U. Fink	1997	4
14	Phase II Study of Weekly High-Dose 5-Fluorouracil and Folinic Acid plus Biweekly Alternating Cisplatin and Epirubicin (FUFACE) in Patients with Advanced Gastric Carcinoma Oncology Research and Treatment ·M. Stahl, U. Vanhoefer, U. Fink, Michael Korn, F. W. Eigler, J. R. Siewert, S. Seeber, H. Wilke	1996	6
15	Diagnostische Wertigkeit digitaler und konventioneller Bildgebung bei intravenöser Urographie RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Cornelia Hundt, P. Kohz, G. Leinsinger, U. Fink, M. Schäizl	1995	1
16	Digitale periphere Angiographie mit Schrittverschiebung und Subtraktion RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·T. Hilbertz, U. Fink, Renata Beck, Herman Berger, U. Eberwein	1991	1
17	Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. Journal of Clinical Oncology ·H. Wilke, P. Preusser, U. Fink, U. Gunzer, H J Meyer, Jochen Meyer, J. R. Siewert, W. Achterrath, Luigi Lenaz, H. Knipp	1989	228
18	Benefit and Costs of Follow-Up Programs in Nonseminomatous Germ Cell Tumors of the Stages Ilb–IV: The Munich Experience Oncology ·Wolfgang E. Berdel, C. Clemm, R. Hartenstein, Jack Nisenbaum, U. Fink, Johann Rastetter, W. Wilmanns	1987	2
19	Neurosurgical experience with magnetic resonance imaging in sellar lesions Acta Neurochirurgica ·R. Oeckler, U. Fink, B Mayr	1986	2
20	Cytotoxic Effects of Alkyl-Lysophospholipids in Human Brain Tumor Cells Oncology ·Wolfgang E. Berdel, Eva Greiner, U. Fink, Kurt S. Zänker, D. Stavrou, Annelie Trappe, Rudolf Fahlbusch, Anneliese Reichert, Johann Rastetter	1984	26

About U. Fink

U. Fink is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Genetics, having authored 165 papers that have together received 7.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (57 papers), Esophageal Cancer Research and Treatment (29 papers), Metastasis and carcinoma case studies (19 papers), Gastrointestinal Tumor Research and Treatment (18 papers), Esophageal and GI Pathology (12 papers), Lung Cancer Diagnosis and Treatment (11 papers), Genetic factors in colorectal cancer (8 papers) and Sphingolipid Metabolism and Signaling (8 papers). The work is most often cited by research in Gastroenterology (1.1k citations), Pulmonary and Respiratory Medicine (4.9k citations), Surgery (4.0k citations), Oncology (1.8k citations) and Radiology, Nuclear Medicine and Imaging (1.3k citations). U. Fink has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Karen Becker, H. J. Stein, Katja Ott, Markus Schwaiger, Wolfgang Weber, J. R. Siewert, Raymonde Busch, Florian Lordick, Heinz Höfler and Jörg‐Rüdiger Siewert. Their work appears in journals such as Journal of Clinical Oncology, World Journal of Surgery, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Cancer and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact